Abstract
Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors with distinct clinical, morphologic, immunohistochemical, and molecular genetic features. GISTs account for 1–3 % of all gastrointestinal tumors, mainly occur in older adults, and are associated with specific KIT and PDGFRA mutations. Most GISTs immunohistochemically express KIT/CD117. GIST can involve the entire gastrointestinal tract, with a predilection for the stomach and the small intestine, whereas the liver is an uncommon primary location. Primary hepatic GISTs are well-circumscribed, firm tumors that may show central necrosis and satellite lesions. The histologic presentation corresponds to that of GISTs in other sites. Much more common than primary hepatic GIST are metastatic lesions, the liver being one of the most common metastatic sites of gastric and intestinal GIST. Liver metastases of GIST can undergo a distinct cystic change upon therapy with imatinib. Radiologically, part of these cysts closely mimic simple nonparasitic liver cysts.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agaimy A, Otto C, Braun A, Geddert H, Schaefer IM, Haller F (2013) Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated phenotype in gastrointestinal stromal tumors (GISTs). Int J Clin Exp Pathol 6:1839–1846
Alecu L, Tulin A, Ursut B, Ursut B, Oproiu A, Obrocea F, Ionescu M (2011) Gastrointestinal stromal tumor with primary hepatic unique location – clinical case (in Romanian). Chirurgia (Bucur) 106:677–681
Andersson J, Sihto H, Meis-Kindblom JM, Joensuu H, Nupponen N, Kindblom LG (2005) NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics. Am J Surg Pathol 29:1170–1176
Antonescu CR, Romaoe S, Zhang L, Nafa K, Hornick JL, Nielsen GP, Mino-Kenudson M et al (2013) Dedifferentiation in gastrointestinal stromal tumor to an anaplastic KIT-negative phenotype: a diagnostic pitfall: morphologic and molecular characterization of 8 cases occurring either de novo or after imatinib therapy. Am J Surg Pathol 37:385–392
Bai YK, Shao YF, Shi SS, Gao YN, Sun YT, Wan YL (2005) Analysis of prognostic factors in gastrointestinal stromal tumors of the small intestine (in Chinese). Zhonghua Wei Chang Wai Ke Za Zhi 8:213–216
Ballarini C, Intra M, Ceretti AP, Prestipino F, Bianchi FM, Sparacio F, Berti E, Perrone S et al (1998) Gastrointestinal stromal tumors: a “benign” tumor with hepatic metastasis after 11 years. Tumori 84:78–81
Barnett CM, Corless CL, Heinrich MC (2013) Gastrointestinal stromal tumors: molecular markers and genetic subtypes. Hematol Oncol Clin N Am 27:871–888
Biasco G, Velo D, Angriman I, Astorino M, Baldan A, Baseggio M, Basso U, Battaglia G et al (2009) Gastrointestinal stromal tumors: report of an audit and review of the literature. Eur J Cancer Prev 18:106–116
Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Rychter M, Dei Tos AP, Emile JF, Gronchi A, Hogendoorn PC et al (2005) Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO. Ann Oncol 16:566–578
Burkill GJ, Badran M, Al-Muderis O, Meirion TJ, Judson IR, Fisher C, Moskovic EC (2003) Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology 226:527–532
Cavallini M, Cecera A, Ciardi A, Caterino S, Ziparo V (2005) Small periampullary duodenal gastrointestinal stromal tumor treated by local excision: report of a case. Tumori 91:264–266
Celestino R, Lima J, Faustino A, Vinagre J, Maximo V, Gouveia A, Soares P, Manuel Lopes J (2012) Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors. Eur J Hum Genet 21:503–510
Chacon M, Roca E, Huertas E, Loria FS, Domenichini E (2005) Complete remission with imatinib in metastatic gastrointestinal stromal tumors. J Clin Oncol 23:6801–6802
Chen MY, Bechtold RE, Savage PD (2002) Cystic change in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (imatinib mesylate). AJR Am J Roentgenol 179:1059–1062
Cheng SP, Huang MJ, Yang TL, Tzen CY, Liu CL, Liu TP, Hsiao SC (2004) Neurofibromatosis with gastrointestinal stromal tumors: insights into the association. Dig Dis Sci 49:1165–1169
Cheung TT, Chok KS, Chan AC, Yau TC, Chan SC, Poon RT, Fan ST, Lo CM (2014) Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour. ANT J Surg 84(11):827–831
Chou A, Chen J, Clarkson A, Samra JS, Clifton-Bligh RJ, Hugh TJ, Gill AJ (2012) Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression. Mod Pathol 25:1307–1313
Colovic R, Micev M, Matic S, Colovic N, Grubor N, Atkinson HD (2013) Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate. Vojnosanit Pregl 70:225–228
Corless CL, McGreevey L, Haley A, Town A, Heinrich MC (2002) KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 160:1567–1572
Corless CL, Fletcher JA, Heinrich MC (2004) Biology of gastrointestinal stromal tumors. J Clin Oncol 22:3813–3825
Corless CL, Schroeder A, Griffith D, Town A, McGreevey L, Harrell P, Shiraga S, Bainbridge T et al (2005) PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol 23:5357–5364
Corless CL, Barnett CM, Heinrich MC (2011) Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer 11:865–878
Croom KF, Perry CM (2003) Imatinib mesylate: in the treatment of gastrointestinal stromal tumors. Drugs 63:513–522
De Chiara A, De Rosa V, Lastoria S, Lastoria S, Franco R, Botti G, Iaffaioli VR, Apice G (2006) Primary gastrointestinal stromal tumor of the liver with lung metastases successfully treated with STI-571 (imatinib mesylate). Front Biosci 11:498–501
Debiec-Rychter M, Wasag B, Stul M, De Wever I, van Oosterom A, Hagemeijer A, Sciot R (2004) Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. J Pathol 202:430–438
Debiec-Rychter M, Cools J, Dumez H, Sciot R, Stul M, Mentens N, Vranckx H, Wasag B et al (2005) Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants. Gastroenterology 128:270–279
DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hundred gastrointestinal stromal tumors. Recurrence patterns and prognostic factors for survival. Ann Surg 231:51–58
Demir L, Ekinci N, Erten C, Kucukzeybek Y, Alacacioglu A, Somali I, Can A, Dirican A et al (2013) Does immunohistochemistry provide additional prognostic data in gastrointestinal stromal tumors? Asian Pac J Cancer Prev 14:4751–4758
Duensing A, Heinrich MC, Fletcher CD, Fletcher JA (2004a) Biology of gastrointestinal stromal tumors: KIT mutations and beyond. Cancer Invest 22:106–116
Duensing A, Medeiros F, McConarty B, Joseph NE, Panigrahy D, Singer S, Fletcher CD et al (2004b) Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). Oncogene 23:3999–4006
Duensing A, Joseph NE, Medeiros F, Smith F, Hornick JL, Heinrich MC, Corless CL et al (2004c) Protein kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs). Cancer Res 64:5127–5131
Duffaud F, Blay JY (2003) Gastrointestinal stromal tumors: biology and treatment. Oncology 65:187–197
Dwight T, Benn DE, Clarkson A, Vilain R, Lipton L, Robinson BG, Clifton-Bligh RJ, Gill AJ (2013) Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors. Am J Surg Pathol 37:226–233
Emile JF, Theou N, Tabone S, Cortez A, Terrier P, Chaumette MT, Julie C, Bertheau P et al (2004) Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors. Clin Gastroenterol Hepatol 2:597–605
Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’Leary TJ et al (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33:459–465
Foo WC, Liegl-Atzwanger B, Lazar AJ (2012) Pathology of gastrointestinal stromal tumors. Clin Med Insights Pathol 5:23–33
Gill AJ (2012) Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia. Pathology 44:285–292
Haller F, Gunawan B, von Heydebreck A, Schwager S, Schulten HJ, Wolf-Salgo J et al (2005) Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors. Clin Cancer Res 11:6589–6597
Haller F, Löbke C, Ruschhaupt M, Schulten HJ, Schwager S, Gunawan B, Armbrust T et al (2008) Increased KIT signaling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (( GISts ) with KIT exon 11 deletions. J Pathol 216:225–235
Hasegawa T, Matsuno Y, Shimoda T, Hirohashi S (2002) Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 33:669–676
Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577–580
Hou YY, Lu SH, Zhou Y, Xu JF, Ji Y, Hou J, Qi WD, Shi Y, Tan YS, Zhu XZ (2009a) Predictive values of clinical and pathological parameters for malignancy of gastrointestinal stromal tumors. Histol Histopathol 24:737–747
Hou YY, Lu SH, Zhou Y, Qi WD, Shi Y, Tan YS, Zhu XZ (2009b) Stage and histological grade of gastrointestinal stromal tumors based on a new approach are strongly associated with clinical behaviors. Mod Pathol 22:556–569
Hu X, Forster J, Damjanov I (2003) Primary malignant gastrointestinal stromal tumor of the liver. Arch Pathol Lab Med 127:1606–1608
Jain P, Jha AK, Rai RR (2009) Cystic hepatic metastasis from gastrointestinal stromal tumor prior to imatinib mimicking a liver abscess. J Gastrointest Liver Dis 18:121–122
Kim HJ, Lim SJ, Park K, Yuh Y, Jang SJ, Choi J (2005) Multiple gastrointestinal stromal tumors with a germline c-kit mutation. Pathol Int 55:655–659
Kitamura Y, Hirota S (2004) Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci 61:2924–2931
Koh JS, Trent J, Chen L, El-Naggar A, Hunt K, Pollock R, Zhang W (2004) Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate. Histol Histopathol 19:565–574
Koh Y, Lee HE, Oh DY, Kim JH, Lee SH, Kim SH, Im SA, Kim TY, Heo DS, Kim WH et al (2012) The lack of CD34 expression in gastrointestinal stromal tumors is related to cystic degeneration following imatinib use. Jpn J Clin Oncol 42:1020–1027
Künstlinger H, Huss S, Merkelbach-Bruse S, Binot E, Kleine MA, Loeser H, Mittler J et al (2013) Gastrointestinal stromal tumors with KIT exon 9 mutations: update on genotype-phenotype correlation and validation of high-resolution melting assay for mutational testing. Am J Surg Pathol 37(11):1648–1659
Lasota J, Miettinen M (2006) KIT and PDGFRA mutations in gastrointestinal stroma tumors (GISTs). Semin Diagn Pathol 23:91–102
Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M (1999) Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 154:53–60
Lasota J, Dansonka-Mieszkowska A, Stachura T, Schneider-Stock R, Kallajoki M, Steigen SE et al (2003) Gastrointestinal stromal tumors with internal tandem duplications in 3′ end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course. Mod Pathol 16:1257–1264
Lasota J, Dansonka-Mieszkowska A, Sobin LH, Miettinen M (2004) A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential. Lab Invest 84:874–883
Laurini JA, Carter JE (2010) Gastrointestinal stromal tumor. A review of the literature. Arch Pathol Lab Med 134:134–141
Lee JR, Joshi V, Griffin JW, Lasota J, Miettinen M (2001) Gastrointestinal autonomic nerve tumor: immunohistochemical and molecular identity with gastrointestinal stromal tumor. Am J Surg Pathol 25:979–987
Lesalnieks I, Rummele P, Dietmaier W, Jantsch T, Zulke C, Schlitt HJ, Hofstadter F, Anthuber M (2005) Factors associated with disease progression in patients with gastrointestinal stromal tumors in the pre-imatinib era. Am J Clin Pathol 124:1–9
Leung KM, Wong S, Chow TC, Lee KC (2002) A malignant gastrointestinal stromal tumor with osteoclast-like giant cells. Arch Pathol Lab Med 126:972–974
Li FP, Fletcher JA, Heinrich MC, Garber JE, Sallan SE, Curiel-Lewandrowski C et al (2005) Familial gastrointestinal stromal tumor syndrome: phenotype and molecular features in a kindred. J Clin Oncol 23:2735–2743
Li ZY, Liang QL, Chen GQ, Zhou Y, Liu QL (2012) Extra-gastrointestinal stromal tumor of the liver diagnosed by ultrasound-guided fine needle aspiration cytology: a case report and review of the literature. Arch Med Sci 8:392–397
Liegl B, Hornick JL, Antonescu CR, Corless CL, Fletcher CD (2009) Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression. Am J Surg Pathol 33:218–226
Liegl-Atzwanger B, Fletcher JA, Fletcher CDM (2010) Gastrointestinal stromal tumors. Virchows Arch 456:111–127
Lo OS, Poon RT, Lam CM, Fan ST (2004) Inflammatory pseudotumor of the liver in association with a gastrointestinal stromal tumor: a case report. World J Gastroenterol 10:1841–1843
Lodish MB, Adams KT, Huynh TT, Prodanov T, Ling A, Chen C, Shusteman S, Jimenez C et al (2010) Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl. Endocrinol Relat Cancer 17:581–588
Luo XL, Liu D, Yang JJ, Zheng MW, Zhang J, Zhou XD (2009) Primary gastrointestinal stromal tumor of the liver: a case report. World J Gastroenterol 15:3704–3707
Martin J, Poveda A, Llombart-Bosch A, Ramos R, Lopez-Guerrero JA, Garcia del Muro J, Maurel J et al (2005) Deletions affecting codons 557–558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS). J Clin Oncol 23:6190–6198
Mazur MT, Clark HB (1983) Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 7:507–519
Medeiros F, Corless CL, Duensing A, Hornick JL, Oliveira AM, Heinrich MC, Fletcher JA, Fletcher CD (2004) KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol 28:889–894
Mendoza-Marin M, Hoang MP, Albores-Saavedra J (2002) Malignant stromal tumor of the gallbladder with interstitial cells of Cajal phenotype. Arch Pathol Lab Med 126:481–483
Miettinen M, Lasota J (2001) Gastrointestinal stromal tumors – definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438:1–12
Miettinen M, Lasota J (2006a) Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 23:70–83
Miettinen M, Lasota J (2006b) Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 130:1466–1478
Miettinen M, Sarlomo-Rikala M, Lasota J (1999) Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 30:1213–1220
Miettinen M, Majidi M, Lasota J (2002) Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer 38(suppl 5):S39–S51
Miettinen M, Lasota J, Sobin LH (2005) Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol 29:1373–1381
Miettinen M, Wang ZF, Sarlomo-Rikala M, Osuch C, Rutkowski P, Lasota J (2011) Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am J Surg Pathol 35:1712–1721
Miettinen M, Killian JK, Wang ZF, Lasota J, Lau C, Jones L, Walker R, Pineda M et al (2013) Immunohistochemical loss of succinate dehydrogenase subunit A (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHA germline mutation. Am J Surg Pathol 37:234–240
Mussi C, Schildhaus HU, Gonchi A, Wardelmann E, Hohenberger P (2008) Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1. Clin Cancer Res 14:4550–4555
Nannini M, Astolfi A, Paterini P, Urbini M, Santini D, Catena F, Indio V, Casadio R et al (2013) Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction. Future Oncol 9:121–126
Ochiai T, Sonoyama T, Kikuchi S, Ikoma H, Kubota T, Nakanishi M, Ichikawa D, Kikuchi S et al (2009) Primary large gastrointestinal stromal tumor of the liver: report of a case. Surg Today 39:633–636
Ozcinar B, Aksakal N, Agcaoglu O, Tukenmez M, Ozemir IA, Barnaros U, Colak N et al (2013) Multiple gastrointestinal stromal tumors and pheochromocytoma in a patient with von Recklinghausen’s disease. Int J Surg Case Rep 4:216–218
Paner GP, Silberman S, Hartman G, Micetich KC, Aranha GV, Alkan S (2003) Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors. Anticancer Res 23:2253–2260
Park SH, Kim MK, Kim H, Song BJ, Chi JG (2004a) Ultrastructural studies of gastrointestinal stromal tumors. J Korean Med Sci 19:234–244
Park JK, Choi SH, Lee S, Min KO, Yun SS, Jeon HM (2004b) Malignant gastrointestinal stromal tumor of the gallbladder. J Korean Med Sci 19:763–767
Pasini B, McWhinney SR, Bei T, Matyakhina L, Stergiopoulos S, Muchow M, Boikos SA et al (2008) Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet 16:79–88
Patnaik S, Jyotsnarani Y, Rammurti S (2012) Radiological features of metastatic gastrointestinal stromal tumors. J Clin Imaging Sci 2:43
Pauls K, Merkelbach-Bruse S, Thal D, Buttner R, Wardelmann E (2005) PDGFRalpha-and c-kit-mutated gastrointestinal stromal tumors (GISTs) are characterized by distinctive histological and immunohistochemical features. Histopathology 46:166–175
Pauwels P, Debiec-Rychter M, Stul M, De Wever I, van Oosterom AT, Sciot R (2005) Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall. Histopathology 47:41–47
Penzel R, Aulmann S, Moock M, Schwarzbach M, Rieker RJ, Mechtersheimer G (2005) The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated. J Clin Pathol 58:634–639
Peshwe HB, Chatni S, Basu S (2005) Imatinib mesylate as therapy for gastrointestinal stromal tumor. Indian J Gastroenterol 24:188
Postow MA, Robson ME (2012) Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features. and therapeutic implications. Clin Sarcoma Res 2:16
Prakash S, Sarran L, Socci N, DeMatteo RP, Eisenstat J, Greco AM, Maki RG, Wexler LH et al (2005) Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J Pediatr Hematol Oncol 27:179–187
Plumb AA, Kochhar R, Leahy M, Taylor MB (2013) Patterns of recurrence of gastrointestinal stromal tumour (GIST) following complete resection: implications for follow-up. Clin Radiol 68:770–775
Rege TA, Wagner AJ, Corless CL, Heinrich MC, Hornick JL (2011) “Pediatric-type” gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior. Am J Surg Pathol 35:495–504
Ricci R, Arena V, Castri F, Martini M, Maggiano N, Murazio M, Pacelli F, Potenza AE et al (2004) Role of p16/INK4a in gastrointestinal stromal tumor progression. Am J Clin Pathol 122:35–43
Richmond JA, Mount SL, Schwarz JE (2004) Gastrointestinal stromal tumor of the stomach with rhabdoid phenotype: immunohistochemical, ultrastructural, and immunoelectron microscopic evaluation. Ultrastruct Pathol 28:165–170
Sakurai S, Hasegawa T, Sakuma Y, Takazawa Y, Motegi A, Nakajima T, Saito K, Fukayama M, Shimoda T (2004) Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: a subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene. Hum Pathol 35:1223–1230
Saleem TB, Ahmed I (2009) Gastrointestinal stromal tumour – evolving concepts. Surgeon 7:36–41
Sanborn RE, Blanke CD (2005) Gastrointestinal stromal tumors and the evolution of targeted therapy. Clin Adv Hematol Oncol 3:647–657
Sandrasegaran K, Rajesh A, Rushing DA, Rydberg J, Akisik FM, Henley JD (2005) Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 15:1407–1414
Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M (1998) CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 11:728–734
Schmieder M, Wolf S, Danner B, Stoehr S, Juchems MS, Wuerl P, Henne-Bruns D et al (2008) p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome. Neoplasia 10:1154–1162
Serkova N, Boros LG (2005) Detection of resistance to imatinib by metabolic profiling: clinical and drug development implications. Am J Pharmacogenomics 5:293–302
Sihto H, Sarlomo-Rikala M, Tynninen O, Tanner M, Andersson LC, Franssila K, Nupponen NN, Joensuu H (2005) KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplification in human solid tumors. J Clin Oncol 23:49–57
Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher CD, Fletcher JA (2002) Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol 20:3898–3905
Steigen SE, Eide TJ (2009) Gastrointestinal stromal tumors (GISTs): a review. APMIS 117:73–86
Subramanian S, West RB, Corless CL, Ou W, Rubin BP, Chu KM, Leung SY, Yuen ST et al (2004) Gastrointestinal stromal tumors (GISTSs) with KIT and PDGFRA mutations have distinct gene expression profiles. Oncogene 23:7780–7790
Sun B, Qie S, Zhang S, Sun T, Zhao X, Gao S, Ni C, Wang X, Liu Y, Zhang L (2008) Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol 39:444–451
Terada T (2009) Gastrointestinal stromal tumor of the digestive organs: a histopathologic study of 31 cases in a single Japanese institute. Int J Clin Exp Pathol 3:162–168
Vlenterie M, Flucke U, Hofmauer LC, Timmers HJ, Gastmeier J, Aust DE, van der Graaf WT et al (2013) Pheochromocytoma and gastrointestinal stromal tumors in patients with neurofibromatosis type I. Am J Med 126:174–180
Wardelmann E, Neidt I, Bierhoff E, Speidel N, Manegold C, Fischer HP, Pfeifer U, Pietsch T (2002) c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant. Mod Pathol 15:125–136
Wasag B, Debiec-Rychter M, Pauwels P, Stul M, Vranckx H, Oosterom AV, Hagemeijer A, Sciot R (2004) Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site. Mod Pathol 17:889–894
Wellmann K, Gohla G, Wenk H (2004) Malignant gastrointestinal stromal tumor (GIST) of the papilla vateri. A rare tumor entity (in German). Chirurg 75:196–199
West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, Zhu S, Ball CA et al (2004) The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 165:107–113
Yamaguchi U, Nakayama R, Honda K, Ichikawa H, Hasegawa T, Shitashige M, Ono M et al (2008) Distinct gene expression-defined classes of gastrointestinal stromal tumor. J Clin Oncol 26:4100–4108
Yamamoto H, Miyamoto Y, Nishihara Y, Kojima A, Imamura M, Kishikawa K, Takase Y et al (2010) Primary gastrointestinal stromal tumor of the liver with PDGFRA gene mutation. Hum Pathol 41:605–609
Yamamoto H, Kohashi K, Fujita A, Oda Y (2013) Fascin-1 overexpression and miR-133b downregulation in the progression of gastrointestinal stromal tumor. Mod Pathol 26(4):563–571
Yang DM, Kim H, Kang JH, Park CH, Kim HS, Shin DB (2005) Computed tomography and sonographic findings of hepatic metastases from gastrointestinal stromal tumors after chemotherapy. J Comput Assist Tomogr 29:592–595
Yi ES, Strong CR, Piao Z, Perucho M, Weidner N (2005) Epithelioid gastrointestinal stromal tumor with PDGFRA activating mutation and immunoreactivity. Appl Immunohistochem Mol Morphol 13:157–161
Yokoi K, Tanaka N, Shoji K, Ishikawa N, Seya T, Horiba K, Kanazawa Y, Yamashita K et al (2005) A study of histopathological assessment criteria for assessing malignancy of gastrointestinal stromal tumor, from a clinical standpoint. J Gastroenterol 40:467–473
Zhou B, Zhang M, Yan S, Zheng S (2014) Primary gastrointestinal stromal tumor of the liver: report of a case. Surg Today 44(6):1142–1146
Zonios D, Soula M, Archimandritis AJ, Revenas K (2003) Cystlike hepatic metastases from gastrointestinal stromal tumors could be seen before any treatment. AJR Am J Roentgenol 181:282
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this entry
Cite this entry
Zimmermann, A. (2017). Gastrointestinal Stromal Tumors (GISTs) of the Liver. In: Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Springer, Cham. https://doi.org/10.1007/978-3-319-26956-6_67
Download citation
DOI: https://doi.org/10.1007/978-3-319-26956-6_67
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26954-2
Online ISBN: 978-3-319-26956-6
eBook Packages: MedicineReference Module Medicine